Leica Biosystems to Acquire StatLab Medical Products
Jul 15, 2026
Acquisitions
Dassault Systèmes to Acquire ArisGlobal from Nordic Capital
July 23, 2026
Nordic Capital has agreed to sell life sciences software provider ArisGlobal to Dassault Systèmes. The deal marks a full exit for Nordic Capital following its investment in 2019 and is expected to close in the second half of 2026, pending regulatory approval.
In a press release, Nordic Capital announced that it has entered into a definitive agreement to sell ArisGlobal to Dassault Systèmes. The transaction represents a full exit for Nordic Capital and is expected to close in the second half of 2026, subject to regulatory approvals.
ArisGlobal, founded in 1989 and based in Waltham, Massachusetts, develops regulatory, safety, and quality software for the life sciences industry. Its LifeSphere platform integrates compliance, pharmacovigilance, and clinical data workflows, while incorporating automation and AI capabilities to reduce manual processing.
Nordic Capital first invested in ArisGlobal in 2019 and made a follow-on investment in 2021. During its ownership, Nordic Capital and ArisGlobal’s management team migrated the company’s products to a cloud-based architecture, expanded the product portfolio, and launched NavaX, a generative AI solution for safety case processing.
Following the acquisition, Dassault Systèmes will combine its research, clinical development, and manufacturing tools with ArisGlobal’s regulatory and safety software to create a broader offering across the life sciences value chain.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
07/23
DarioHealth Prices $23.5 Million Stock Offering at Market Value
07/23
Health Endeavors Launches AI Care Suite and Receives Investment from Decathlon Capital Partners
07/23
Agilisium Named Select Services Partner in Anthropic’s Claude Partner Network
07/23
Tally and Liminal Partner to Automate Specialty Healthcare Billing with AI
07/23
Moon Surgical and KARL STORZ Form Collaboration on Laparoscopic Platforms
More from: Funding
07/23
DarioHealth Prices $23.5 Million Stock Offering at Market Value
07/23
Health Endeavors Launches AI Care Suite and Receives Investment from Decathlon Capital Partners
07/23
Trooly Raises $20 Million and Launches AI Research Platform for In-Depth Consumer Interviews
07/23
StrongestLayer Raises $4.1 Million, Expands Seed Round to $9.3 Million for AI Email Security
07/23
OpenAI Plans $750 Billion Infrastructure Spending Through 2030
Subscribe to AI Funding Brief
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read more